Author

Clara G. Altomare

Columbia UniversityORCID 0000-0002-7564-704XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:structural biology· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Ali H. EllebedyiD· 1 shared Christopher U.T. HelleniD· 1 shared Daniel C. AdelsbergiD· 1 shared Deepika JaiswaliD· 1 shared F.J. Acosta-ReyesiD· 1 shared Florian KrammeriD· 1 shared Goran BajiciD· 1 shared Iden A. SapseiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ali H. EllebedyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Structural Studies of Nedicistrovirus IRES-Driven, Initiation Factor-independent Translation Shed Light on Key Steps of Eukaryotic Translation Elongation

Swastik De, Clara G. Altomare, Irina S. Abaeva, Prikshat Dadhwal, Priyanka Garg, F.J. Acosta-Reyes, Zuben P. Brown, Tatyana V. Pestova, Christopher U.T. Hellen, Joachim Frank

The paper determines high-resolution structures of NediV IRES-mediated translation initiation complexes and their transition to elongation, revealing structural changes and interactions during viral translation.

Nucleic Acids Research · May 10, 2026Peer-reviewedBiochemistry

Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies

Deepika Jaiswal, Clara G. Altomare, Daniel C. Adelsberg, Iden A. Sapse, Florian Krammer, Viviana R. Simon, Ali H. Ellebedy, Goran Bajic

The paper assesses the breadth and vulnerability of vaccine-induced SARS-CoV-2 neutralizing antibodies against emerging variants by analyzing their binding to conserved and variant-associated epitopes.

bioRxiv · Mar 4, 2026 · PreprintImmunology